Ascendis Pharma A/S (ASND)
226.69
-2.56
(-1.12%)
USD |
NASDAQ |
Apr 06, 16:00
226.65
-0.04
(-0.02%)
After-Hours: 20:00
Ascendis Pharma SG&A Expense (TTM) : 519.00M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Novo Nordisk A/S | 10.66B |
| DBV Technologies SA | 36.08M |
| Evaxion AS | 1.491M |
| Bicycle Therapeutics Plc | 79.52M |
| Biodexa Pharmaceuticals Plc | 6.375M |